{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:44:21Z","timestamp":1769121861452,"version":"3.49.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Intravenous thrombolysis combined with tirofiban (IVT plus tirofiban) has been reported to be more effective than IVT alone in preventing early neurological deterioration (END) and improving 3-month functional outcomes in patients with ischemic stroke. This study aimed to assess the radiological efficacy and safety of simultaneous (or within 60\u202fmin) IVT plus tirofiban versus IVT alone specifically in patients with anterior choroidal infarction (ACI) or paramedian pontine infarction (PPI), two subtypes with a high risk of END.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center, retrospective study including consecutive patients aged \u226518\u202fyears treated during two distinct periods: one with standard IVT alone and one with IVT plus tirofiban. The primary endpoint was \u226520% reduction in lesion volume on 24-h diffusion-weighted imaging (DWI). Secondary endpoints included early clinical improvement at 24\u202fh and 7\u202fdays (or discharge), functional independence [modified Rankin Scale (mRS) scores \u22642 and \u22641] at 3\u202fmonths, and END. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and major systemic bleeding (MSB). A subgroup analysis compared clinical outcomes in patients with \u201clesion reversal\u201d versus patients with no \u201clesion reversal.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 58 patients were analyzed (30 IVT plus tirofiban; 28 IVT alone). Lesion reversal \u226520% was more frequently observed in the IVT plus tirofiban group (adjusted odds ratio, 8.58; 95% CI, 2.09\u201335.28;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001). No significant differences were found between groups for END or 3-month functional outcomes (mRS \u22642 or \u22641). One non-fatal MSB occurred in the IVT alone group. No cases of sICH were observed in either group. Overall lesion reversal was significantly associated with better early and late outcomes, and with IVT plus tirofiban treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusion<\/jats:title>\n                    <jats:p>This study suggests that IVT plus tirofiban improves radiological outcomes and may be a promising therapeutic option in patients with ACI\/PPI, without increasing the risk of bleeding compared to IVT alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                      , identifier NCT05733507.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1692576","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:48:36Z","timestamp":1769060916000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of simultaneous infusion of tirofiban with intravenous thrombolysis in patients with acute anterior choroidal or paramedian pontine infarction: TITACIPPI study"],"prefix":"10.3389","volume":"16","author":[{"given":"Moussa","family":"Toudou-Daouda","sequence":"first","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]},{"name":"Department of Neurology, Amirou Boubacar Diallo National Hospital","place":["Niamey, Niger"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djibril","family":"Soumah","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Bentamra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana-Rahamatou","family":"Aminou-Tassiou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Baby","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Lhermitte","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Altarcha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manvel","family":"Aghasaryan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Smadja","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]},{"name":"Universit\u00e9 Paris-Saclay","place":["Paris, France"]},{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Chausson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier Sud-Francilien","place":["Corbeil-Essonnes, France"]},{"name":"Universit\u00e9 Paris-Saclay","place":["Paris, France"]},{"name":"Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/STROKEAHA.111.632307","article-title":"Topographic location of acute pontine infarction is associated with the development of progressive motor deficits","volume":"43","author":"Oh","year":"2012","journal-title":"Stroke"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2009.02.323","article-title":"Acute ischemic stroke in anterior choroidal artery territory","volume":"281","author":"Ois","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.013","article-title":"Infarction in the anterior choroidal artery territory: clinical progression and prognosis factors","volume":"23","author":"Chausson","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1747-4949.2012.00953.x","article-title":"The progressive course of neurological symptoms in anterior choroidal artery infarcts","volume":"10","author":"Derflinger","year":"2015","journal-title":"Int J Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1212\/WNL.39.9.1246","article-title":"Intracranial branch atheromatous disease: a neglected, understudied, and underused concept","volume":"39","author":"Caplan","year":"1989","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000073053","article-title":"Etiology and long-term prognosis of unilateral paramedian pontine infarction with progressive symptoms","volume":"50","author":"Kunz","year":"2003","journal-title":"Eur Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105826","DOI":"10.1016\/j.clineuro.2020.105826","article-title":"Acute anterior choroidal artery territory infarction: a retrospective study","volume":"195","author":"Cheng","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.012","article-title":"Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease","volume":"22","author":"Deguchi","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/STROKEAHA.116.014413","article-title":"Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients","volume":"47","author":"Li","year":"2016","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","article-title":"Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke","volume":"28","author":"Liu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12883-022-02808-w","article-title":"Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study","volume":"22","author":"Liang","year":"2022","journal-title":"BMC Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jns.2014.09.048","article-title":"Early infarct growth predicts long-term clinical outcome in ischemic stroke","volume":"347","author":"Kim","year":"2014","journal-title":"J Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fneur.2020.00581","article-title":"Efficacy and safety of intravenous thrombolysis on acute branch atheromatous disease: a retrospective case-control study","volume":"11","author":"Wu","year":"2020","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","article-title":"Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial","volume":"7","author":"Anderson","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1161\/STROKEAHA.123.042491","article-title":"Diffusion-weighted imaging lesion reversal in older patients with stroke treated with mechanical thrombectomy","volume":"54","author":"Scopelliti","year":"2023","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/23969873231225069","article-title":"Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Guo","year":"2024","journal-title":"Eur Stroke J"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1692576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:48:37Z","timestamp":1769060917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1692576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":17,"alternative-id":["10.3389\/fneur.2025.1692576"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1692576","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1692576"}}